Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel

Children represent a significant proportion of the global tuberculosis (TB) burden, and may be disproportionately more affected by its most severe clinical manifestations. Currently available treatments for pediatric drug-susceptible (DS) and drug-resistant (DR) TB, albeit generally effective, are h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet Infect Dis
Main Authors: Nachman, Sharon, Ahmed, Amina, Amanullah, Farhana, Becerra, Mercedes C, Botgros, Radu, Brigden, Grania, Browning, Renee, Gardiner, Elizabeth, Hafner, Richard, Hesseling, Anneke, How, Cleotilde, Jean-Philippe, Patrick, Lessem, Erica, Makhene, Mamodikoe, Mbelle, Nontombi, Marais, Ben, McIlleron, Helen, Mc Neeley, David F, Mendel, Carl, Murray, Stephen, Navarro, Eileen, Oramasionwu, Gloria E, Porcalla, Ariel R, Powell, Clydette, Powell, Mair, Rigaud, Mona, Rouzier, Vanessa, Samson, Pearl, Schaaf, H. Simon, Shah, Seema, Starke, Jeff, Swaminathan, Soumya, Wobudeya, Eric, Worrell, Carol
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4471052/
https://ncbi.nlm.nih.gov/pubmed/25957923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00007-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Cargando...

Títulos similares